Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.04
COO's Cash-to-Debt is ranked lower than
94% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. COO: 0.04 )
Ranked among companies with meaningful Cash-to-Debt only.
COO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.08 Max: 2.39
Current: 0.04
0
2.39
Equity-to-Asset 0.65
COO's Equity-to-Asset is ranked higher than
52% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. COO: 0.65 )
Ranked among companies with meaningful Equity-to-Asset only.
COO' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.09  Med: 0.57 Max: 0.8
Current: 0.65
-0.09
0.8
Debt-to-Equity 0.39
COO's Debt-to-Equity is ranked lower than
60% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. COO: 0.39 )
Ranked among companies with meaningful Debt-to-Equity only.
COO' s Debt-to-Equity Range Over the Past 10 Years
Min: -47.1  Med: 0.52 Max: 107.8
Current: 0.39
-47.1
107.8
Interest Coverage 13.81
COO's Interest Coverage is ranked lower than
67% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.83 vs. COO: 13.81 )
Ranked among companies with meaningful Interest Coverage only.
COO' s Interest Coverage Range Over the Past 10 Years
Min: 1.07  Med: 12.72 Max: 38.48
Current: 13.81
1.07
38.48
Piotroski F-Score: 7
Altman Z-Score: 5.64
Beneish M-Score: -2.60
WACC vs ROIC
6.76%
8.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 18.83
COO's Operating Margin % is ranked higher than
83% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.15 vs. COO: 18.83 )
Ranked among companies with meaningful Operating Margin % only.
COO' s Operating Margin % Range Over the Past 10 Years
Min: 4.82  Med: 16.44 Max: 19.61
Current: 18.83
4.82
19.61
Net Margin % 16.45
COO's Net Margin % is ranked higher than
83% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. COO: 16.45 )
Ranked among companies with meaningful Net Margin % only.
COO' s Net Margin % Range Over the Past 10 Years
Min: -1.18  Med: 12.26 Max: 18.65
Current: 16.45
-1.18
18.65
ROE % 12.07
COO's ROE % is ranked higher than
65% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.37 vs. COO: 12.07 )
Ranked among companies with meaningful ROE % only.
COO' s ROE % Range Over the Past 10 Years
Min: -0.79  Med: 8.75 Max: 12.88
Current: 12.07
-0.79
12.88
ROA % 7.41
COO's ROA % is ranked higher than
71% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.13 vs. COO: 7.41 )
Ranked among companies with meaningful ROA % only.
COO' s ROA % Range Over the Past 10 Years
Min: -0.45  Med: 5.35 Max: 9.74
Current: 7.41
-0.45
9.74
ROC (Joel Greenblatt) % 27.63
COO's ROC (Joel Greenblatt) % is ranked higher than
71% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.96 vs. COO: 27.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
COO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 5.39  Med: 19.99 Max: 29.5
Current: 27.63
5.39
29.5
3-Year Revenue Growth Rate 7.90
COO's 3-Year Revenue Growth Rate is ranked higher than
63% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.80 vs. COO: 7.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
COO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -62.6  Med: 8.4 Max: 30.8
Current: 7.9
-62.6
30.8
3-Year EBITDA Growth Rate 5.70
COO's 3-Year EBITDA Growth Rate is ranked higher than
51% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. COO: 5.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
COO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -70.8  Med: 14.55 Max: 62.2
Current: 5.7
-70.8
62.2
3-Year EPS without NRI Growth Rate -2.10
COO's 3-Year EPS without NRI Growth Rate is ranked lower than
56% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. COO: -2.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
COO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -47.7  Med: 9.1 Max: 623.7
Current: -2.1
-47.7
623.7
GuruFocus has detected 6 Warning Signs with The Cooper Companies Inc $COO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» COO's 30-Y Financials

Financials (Next Earnings Date: 2017-12-08 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

COO Guru Trades in Q3 2016

Pioneer Investments 188,076 sh (New)
Joel Greenblatt 14,334 sh (New)
Paul Tudor Jones 4,816 sh (+43.55%)
Ken Fisher 114,974 sh (+7.54%)
Steven Cohen 270,800 sh (+0.89%)
Mario Gabelli 28,500 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 205,000 sh (unchged)
Ron Baron 264,731 sh (-2.00%)
David Carlson 190,000 sh (-9.52%)
Manning & Napier Advisors, Inc 354,911 sh (-36.96%)
» More
Q4 2016

COO Guru Trades in Q4 2016

Jim Simons 213,098 sh (New)
Joel Greenblatt 133,681 sh (+832.61%)
Pioneer Investments 325,499 sh (+73.07%)
Ken Fisher 115,353 sh (+0.33%)
Ron Baron 264,731 sh (unchged)
David Carlson 190,000 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Manning & Napier Advisors, Inc 350,771 sh (-1.17%)
Mario Gabelli 27,500 sh (-3.51%)
Eaton Vance Worldwide Health Sciences Fund 152,300 sh (-25.71%)
» More
Q1 2017

COO Guru Trades in Q1 2017

Ronald Muhlenkamp 170 sh (New)
Pioneer Investments 518,222 sh (+59.21%)
Ronald Muhlenkamp 1,000 sh (unchged)
Mario Gabelli 27,500 sh (unchged)
David Carlson 190,000 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Ron Baron 253,931 sh (-4.08%)
Jim Simons 191,498 sh (-10.14%)
Ken Fisher 102,760 sh (-10.92%)
Joel Greenblatt 11,602 sh (-91.32%)
Eaton Vance Worldwide Health Sciences Fund 85,807 sh (-43.66%)
» More
Q2 2017

COO Guru Trades in Q2 2017

Caxton Associates 2,400 sh (New)
Pioneer Investments 1,226,250 sh (+136.63%)
Ken Fisher 121,995 sh (+18.72%)
Ron Baron 254,331 sh (+0.16%)
Ronald Muhlenkamp 1,000 sh (unchged)
Ronald Muhlenkamp 170 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 85,807 sh (unchged)
Mario Gabelli 24,000 sh (-12.73%)
David Carlson 165,000 sh (-13.16%)
Jim Simons 138,500 sh (-27.68%)
Joel Greenblatt 4,248 sh (-63.39%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2017-06-30 Add 0.16%$196.29 - $246.76 $ 233.388%254,331
Ken Fisher 2017-06-30 Add 18.72%0.01%$196.29 - $246.76 $ 233.388%121,995
Mario Gabelli 2017-06-30 Reduce -12.73%$196.29 - $246.76 $ 233.388%24,000
Joel Greenblatt 2017-06-30 Reduce -63.39%0.02%$196.29 - $246.76 $ 233.388%4,248
Ron Baron 2017-03-31 Reduce -4.08%0.01%$175.15 - $201.14 $ 233.3823%253,931
Ken Fisher 2017-03-31 Reduce -10.92%$175.15 - $201.14 $ 233.3823%102,760
Joel Greenblatt 2017-03-31 Reduce -91.32%0.27%$175.15 - $201.14 $ 233.3823%11,602
Ronald Muhlenkamp 2017-03-31 New Buy0.01%$175.15 - $201.14 $ 233.3823%170
Joel Greenblatt 2016-12-31 Add 832.61%0.27%$159.5 - $182.9 $ 233.3834%133,681
Ken Fisher 2016-12-31 Add 0.33%$159.5 - $182.9 $ 233.3834%115,353
Mario Gabelli 2016-12-31 Reduce -3.51%$159.5 - $182.9 $ 233.3834%27,500
Ron Baron 2016-09-30 Reduce -2.00%$176.02 - $189.9 $ 233.3828%264,731
Ken Fisher 2016-09-30 Add 7.54%$176.02 - $189.9 $ 233.3828%114,974
Joel Greenblatt 2016-09-30 New Buy0.03%$176.02 - $189.9 $ 233.3828%14,334
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339115    SIC: 3841
Compare:NYSE:RMD, NAS:HOLX, NAS:XRAY, NYSE:WAT, NYSE:MTD, NYSE:WST, NYSE:HRC, NAS:ICUI, NYSE:CMD, NAS:PODD, NYSE:HAE, NYSE:HYH, NAS:MMSI, NAS:NXTM, NAS:OSUR, NAS:ATRI, NAS:IRTC, NYSE:GKOS, NAS:LMNX, NYSE:BCR » details
Traded in other countries:CP6.Germany, COO.Mexico,
Headquarter Location:USA
The Cooper Companies Inc is a medical device company operating through its subsidiaries. It manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare.

Cooper Companies operates two units: Cooper Vision and Cooper Surgical. Accounting for over 80% of total sales, Cooper Vision is one of the world's top four developers and manufacturers of contact lenses. Over 50% of Cooper Vision's sales are in international territories. At roughly 20% of total sales, Cooper Surgical develops and manufactures diagnostic and surgical products for gynecologists and obstetricians.

Guru Investment Theses on The Cooper Companies Inc

Baron Funds Comments on The Cooper Companies - Jan 26, 2016

Shares of The Cooper Companies, Inc. (NYSE:COO), a global contact lens manufacturer, fell after its earnings fell short of Wall Street expectations. Results were negatively impacted by missteps in integrating its recent acquisition of Sauflon Pharmaceuticals Ltd., a British contact lens company, as well as fallout from new competitive lenses. Management projected moderating market share gains and lowered the company’s targeted five-year growth rate. Although disappointed, we remain cautiously optimistic, given Cooper’s reduced valuation and our belief that its revised earnings targets are achievable. Furthermore, we believe that shifts in the contact lens market toward greater adoption of silicon hydrogel lenses and daily modalities will play to Cooper’s strengths.



From Baron Funds' Baron Asset Fund commentary for fourth quarter 2015.



Check out Ron Baron latest stock trades

Top Ranked Articles about The Cooper Companies Inc

The Biggest Drop in More Than a Year 3 stocks down on Tuesday
In Tuesday trading, McDonald's Corp. (NYSE:MCD) shares traded lower by more than 3% after data from research firm M Science that concluded that sales projections are below Wall Street’s estimates. Read more...
The Cooper Companies Announces Definitive Agreement to Acquire PARAGARD® IUD From Teva
The Cooper Companies to Present at Upcoming Financial Conferences
Pioneer Investments Buys Citigroup, Berkshire, Gilead The guru's largest 2nd-quarter investments
Pioneer Investments (TradesPortfolio) operates in wide areas of investment vehicles – mutual funds, single manager hedge funds, funds of hedge funds, structured products, segregated and managed accounts, institutional funds. During the second quarter the firm bought shares in the following stocks: Read more...
The Cooper Companies Announces Release Date for Third Quarter 2017
Three-Year Study Indicates Pioneering Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59%
Insiders Roundup: Medley Capital, LHC Group Largest insider buys and sales of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and All Insider Sales to “$5,000,000+.” Read more...
The Cooper Companies to Present at William Blair Conference
The Cooper Companies to Present at Jefferies Healthcare Conference
The Cooper Companies Announces Release Date for Second Quarter 2017

Ratios

vs
industry
vs
history
PE Ratio 33.48
COO's PE Ratio is ranked lower than
63% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.55 vs. COO: 33.48 )
Ranked among companies with meaningful PE Ratio only.
COO' s PE Ratio Range Over the Past 10 Years
Min: 8.06  Med: 22.6 Max: 1011.75
Current: 33.48
8.06
1011.75
Forward PE Ratio 21.79
COO's Forward PE Ratio is ranked higher than
66% of the 38 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.25 vs. COO: 21.79 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 33.48
COO's PE Ratio without NRI is ranked lower than
63% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.55 vs. COO: 33.48 )
Ranked among companies with meaningful PE Ratio without NRI only.
COO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.06  Med: 22.6 Max: 1011.75
Current: 33.48
8.06
1011.75
Price-to-Owner-Earnings 31.20
COO's Price-to-Owner-Earnings is ranked lower than
51% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.16 vs. COO: 31.20 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
COO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.32  Med: 24.13 Max: 195
Current: 31.2
13.32
195
PB Ratio 3.68
COO's PB Ratio is ranked lower than
59% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.29 vs. COO: 3.68 )
Ranked among companies with meaningful PB Ratio only.
COO' s PB Ratio Range Over the Past 10 Years
Min: 0.37  Med: 1.94 Max: 4.09
Current: 3.68
0.37
4.09
PS Ratio 5.52
COO's PS Ratio is ranked lower than
70% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.24 vs. COO: 5.52 )
Ranked among companies with meaningful PS Ratio only.
COO' s PS Ratio Range Over the Past 10 Years
Min: 0.51  Med: 2.95 Max: 5.94
Current: 5.52
0.51
5.94
Price-to-Free-Cash-Flow 25.25
COO's Price-to-Free-Cash-Flow is ranked higher than
54% of the 70 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.92 vs. COO: 25.25 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
COO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.35  Med: 24.42 Max: 348.8
Current: 25.25
7.35
348.8
Price-to-Operating-Cash-Flow 19.64
COO's Price-to-Operating-Cash-Flow is ranked higher than
52% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.25 vs. COO: 19.64 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
COO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.53  Med: 15.22 Max: 21.95
Current: 19.64
5.53
21.95
EV-to-EBIT 31.90
COO's EV-to-EBIT is ranked lower than
76% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.41 vs. COO: 31.90 )
Ranked among companies with meaningful EV-to-EBIT only.
COO' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.2  Med: 21.3 Max: 72.2
Current: 31.9
11.2
72.2
EV-to-EBITDA 21.59
COO's EV-to-EBITDA is ranked lower than
65% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.62 vs. COO: 21.59 )
Ranked among companies with meaningful EV-to-EBITDA only.
COO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 15 Max: 24.5
Current: 21.59
6.8
24.5
EV-to-Revenue 6.02
COO's EV-to-Revenue is ranked lower than
73% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.43 vs. COO: 6.02 )
Ranked among companies with meaningful EV-to-Revenue only.
COO' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.4  Med: 3.6 Max: 6.5
Current: 6.02
1.4
6.5
PEG Ratio 4.19
COO's PEG Ratio is ranked lower than
65% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. COO: 4.19 )
Ranked among companies with meaningful PEG Ratio only.
COO' s PEG Ratio Range Over the Past 10 Years
Min: 0.79  Med: 2.43 Max: 21.32
Current: 4.19
0.79
21.32
Shiller PE Ratio 53.69
COO's Shiller PE Ratio is ranked lower than
55% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.16 vs. COO: 53.69 )
Ranked among companies with meaningful Shiller PE Ratio only.
COO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.2  Med: 36.79 Max: 59.88
Current: 53.69
7.2
59.88
Current Ratio 2.51
COO's Current Ratio is ranked higher than
54% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. COO: 2.51 )
Ranked among companies with meaningful Current Ratio only.
COO' s Current Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.14 Max: 4.36
Current: 2.51
0.86
4.36
Quick Ratio 1.29
COO's Quick Ratio is ranked lower than
60% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. COO: 1.29 )
Ranked among companies with meaningful Quick Ratio only.
COO' s Quick Ratio Range Over the Past 10 Years
Min: 0.56  Med: 1.21 Max: 4.19
Current: 1.29
0.56
4.19
Days Inventory 200.27
COO's Days Inventory is ranked lower than
77% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.43 vs. COO: 200.27 )
Ranked among companies with meaningful Days Inventory only.
COO' s Days Inventory Range Over the Past 10 Years
Min: 167.05  Med: 203.22 Max: 230.08
Current: 200.27
167.05
230.08
Days Sales Outstanding 58.49
COO's Days Sales Outstanding is ranked higher than
63% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.12 vs. COO: 58.49 )
Ranked among companies with meaningful Days Sales Outstanding only.
COO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.77  Med: 58.23 Max: 63.16
Current: 58.49
52.77
63.16
Days Payable 51.99
COO's Days Payable is ranked lower than
55% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.69 vs. COO: 51.99 )
Ranked among companies with meaningful Days Payable only.
COO' s Days Payable Range Over the Past 10 Years
Min: 27.82  Med: 52.54 Max: 70.39
Current: 51.99
27.82
70.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.03
COO's Dividend Yield % is ranked lower than
100% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.17 vs. COO: 0.03 )
Ranked among companies with meaningful Dividend Yield % only.
COO' s Dividend Yield % Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 0.52
Current: 0.03
0.02
0.52
Dividend Payout Ratio 0.01
COO's Dividend Payout Ratio is ranked higher than
99% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. COO: 0.01 )
Ranked among companies with meaningful Dividend Payout Ratio only.
COO' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.01 Max: 0.04
Current: 0.01
0.01
0.04
Forward Dividend Yield % 0.03
COO's Forward Dividend Yield % is ranked lower than
100% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. COO: 0.03 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.03
COO's 5-Year Yield-on-Cost % is ranked lower than
99% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. COO: 0.03 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
COO' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 0.52
Current: 0.03
0.02
0.52
3-Year Average Share Buyback Ratio -0.50
COO's 3-Year Average Share Buyback Ratio is ranked higher than
73% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.00 vs. COO: -0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
COO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.9  Med: -3.2 Max: 1.2
Current: -0.5
-12.9
1.2

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 41.97
COO's Price-to-Tangible-Book is ranked lower than
98% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. COO: 41.97 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
COO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.58  Med: 7.78 Max: 1768
Current: 41.97
0.58
1768
Price-to-Intrinsic-Value-Projected-FCF 2.10
COO's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
50% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.25 vs. COO: 2.10 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
COO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.55  Med: 1.67 Max: 10.94
Current: 2.1
0.55
10.94
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.13
COO's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
68% of the 22 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. COO: 3.13 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
COO' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.98  Med: 2.03 Max: 81.4
Current: 3.13
0.98
81.4
Price-to-Median-PS-Value 1.87
COO's Price-to-Median-PS-Value is ranked lower than
84% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. COO: 1.87 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
COO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.05  Med: 0.87 Max: 2.47
Current: 1.87
0.05
2.47
Price-to-Peter-Lynch-Fair-Value 6.00
COO's Price-to-Peter-Lynch-Fair-Value is ranked lower than
90% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.48 vs. COO: 6.00 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
COO' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.6  Med: 1.43 Max: 70
Current: 6
0.6
70
Price-to-Graham-Number 7.90
COO's Price-to-Graham-Number is ranked lower than
99% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. COO: 7.90 )
Ranked among companies with meaningful Price-to-Graham-Number only.
COO' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.78  Med: 2.7 Max: 54.57
Current: 7.9
0.78
54.57
Earnings Yield (Greenblatt) % 3.13
COO's Earnings Yield (Greenblatt) % is ranked higher than
53% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. COO: 3.13 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
COO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.4  Med: 4.7 Max: 8.9
Current: 3.13
1.4
8.9
Forward Rate of Return (Yacktman) % 7.86
COO's Forward Rate of Return (Yacktman) % is ranked lower than
57% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.23 vs. COO: 7.86 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
COO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -1.4  Med: 12.7 Max: 22.9
Current: 7.86
-1.4
22.9

More Statistics

Revenue (TTM) (Mil) $2,096.11
EPS (TTM) $ 6.97
Beta0.85
Short Percentage of Float1.80%
52-Week Range $158.73 - 256.39
Shares Outstanding (Mil)48.86

Analyst Estimate

Oct17 Oct18
Revenue (Mil $) 2,142 2,300
EPS ($) 9.71 10.85
EPS without NRI ($) 9.71 10.85
EPS Growth Rate
(Future 3Y To 5Y Estimate)
11.84%
Dividends per Share ($) 0.06 0.07

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}